Dovato (dolutegravir and lamivudine)

Dovato is a novel pharmaceutical used to treat HIV-I in adults and was approved in April of 2019. Dovato is a combination drug that includes two previously approved drug, dolutegravir, approved for the treatment of HIV-I in 2013, and lamivudine, approved for the treatment of HIV/AIDS in 1995. Dolutegravir is an integrase strand transfer inhibitor […]

Privacy Statement